Northwest & Ethical Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.8M | Sell |
27,350
-7,151
| -21% | -$7.31M | 0.76% | 28 |
|
|
2026
Q1 | $31.7M | Buy |
34,501
+1,371
| +4% | +$1.39M | 0.73% | 34 |
|
|
2025
Q4 | $35.6M | Buy |
33,130
+115
| +0.3% | +$110K | 0.8% | 24 |
|
|
2025
Q3 | $25.1M | Buy |
33,015
+4,410
| +15% | +$3.28M | 0.59% | 48 |
|
|
2025
Q2 | $22.3M | Sell |
28,605
-1,301
| -4% | -$1.01M | 0.55% | 56 |
|
|
2025
Q1 | $24.7M | Buy |
29,906
+2,589
| +9% | +$2.15M | 0.67% | 39 |
|
|
2024
Q4 | $21.1M | Sell |
27,317
-7,960
| -23% | -$6.59M | 0.57% | 52 |
|
|
2024
Q3 | $31.3M | Buy |
35,277
+7,154
| +25% | +$6.43M | 0.83% | 23 |
|
|
2024
Q2 | $25.5M | Buy |
28,123
+5,730
| +26% | +$4.58M | 0.73% | 33 |
|
|
2024
Q1 | $17.4M | Buy |
22,393
+411
| +2% | +$292K | 0.5% | 64 |
|
|
2023
Q4 | $12.8M | Sell |
21,982
-3,440
| -14% | -$2.01M | 0.39% | 84 |
|
|
2023
Q3 | $13.7M | Sell |
25,422
-15,188
| -37% | -$7.83M | 0.46% | 73 |
|
|
2023
Q2 | $19M | Buy |
40,610
+11,021
| +37% | +$4.62M | 0.61% | 45 |
|
|
2023
Q1 | $10.2M | Sell |
29,589
-6,273
| -17% | -$2.12M | 0.34% | 97 |
|
|
2022
Q4 | $13.1M | Buy |
35,862
+6,202
| +21% | +$2.2M | 0.45% | 76 |
|
|
2022
Q3 | $9.59M | Buy |
29,660
+625
| +2% | +$198K | 0.38% | 84 |
|
|
2022
Q2 | $9.41M | Sell |
29,035
-793
| -3% | -$238K | 0.35% | 88 |
|
|
2022
Q1 | $8.54M | Sell |
29,828
-6,996
| -19% | -$1.8M | 0.27% | 108 |
|
|
2021
Q4 | $10.2M | Sell |
36,824
-2,379
| -6% | -$603K | 0.3% | 101 |
|
|
2021
Q3 | $9.06M | Sell |
39,203
-12,073
| -24% | -$2.98M | 0.3% | 105 |
|
|
2021
Q2 | $11.8M | Sell |
51,276
-1,719
| -3% | -$345K | 0.38% | 83 |
|
|
2021
Q1 | $9.9M | Sell |
52,995
-4,165
| -7% | -$815K | 0.35% | 91 |
|
|
2020
Q4 | $9.65M | Buy |
57,160
+7,673
| +16% | +$1.15M | 0.37% | 91 |
|
|
2020
Q3 | $7.33M | Buy |
49,487
+2,514
| +5% | +$389K | 0.32% | 103 |
|
|
2020
Q2 | $7.71M | Sell |
46,973
-17,291
| -27% | -$2.65M | 0.37% | 92 |
|
|
2020
Q1 | $8.91M | Sell |
64,264
-5,664
| -8% | -$778K | 0.52% | 55 |
|
|
2019
Q4 | $9.19M | Sell |
69,928
-5,906
| -8% | -$685K | 0.41% | 73 |
|
|
2019
Q3 | $8.48M | Buy |
75,834
+9,784
| +15% | +$1.09M | 0.41% | 76 |
|
|
2019
Q2 | $7.32M | Buy |
66,050
+13,216
| +25% | +$1.56M | 0.37% | 87 |
|
|
2019
Q1 | $6.86M | Buy |
52,834
+23,238
| +79% | +$2.83M | 0.36% | 82 |
|
|
2018
Q4 | $3.42M | Buy |
29,596
+17,536
| +145% | +$1.96M | 0.2% | 148 |
|
|
2018
Q3 | $1.29M | Sell |
12,060
-39,280
| -77% | -$3.93M | 0.08% | 272 |
|
|
2018
Q2 | $4.38M | Buy |
51,340
+2,900
| +6% | +$238K | 0.29% | 106 |
|
|
2018
Q1 | $3.75M | Buy |
48,440
+2,800
| +6% | +$225K | 0.25% | 121 |
|
|
2017
Q4 | $3.85M | Buy |
45,640
+16,069
| +54% | +$1.37M | 0.25% | 124 |
|
|
2017
Q3 | $2.53M | Buy |
29,571
+1,300
| +5% | +$107K | 0.16% | 175 |
|
|
2017
Q2 | $2.29M | Buy |
28,271
+800
| +3% | +$65.3K | 0.16% | 170 |
|
|
2017
Q1 | $2.31M | Sell |
27,471
-28,600
| -51% | -$2.29M | 0.16% | 170 |
|
|
2016
Q4 | $4.12M | Sell |
56,071
-55,229
| -50% | -$4.11M | 0.28% | 87 |
|
|
2016
Q3 | $8.93M | Sell |
111,300
-105,200
| -49% | -$8.42M | 0.63% | 32 |
|
|
2016
Q2 | $17M | Buy |
216,500
+166,900
| +336% | +$12.6M | 1.29% | 16 |
|
|
2016
Q1 | $3.57M | Sell |
49,600
-2,900
| -6% | -$219K | 0.24% | 108 |
|
|
2015
Q4 | $4.42M | Sell |
52,500
-92,050
| -64% | -$7.64M | 0.32% | 91 |
|
|
2015
Q3 | $12.1M | Sell |
144,550
-115,800
| -44% | -$9.78M | 0.93% | 27 |
|
|
2015
Q2 | $21.7M | Buy |
260,350
+79,150
| +44% | +$6.03M | 1.43% | 16 |
|
|
2015
Q1 | $13.2M | Sell |
181,200
-79,000
| -30% | -$5.62M | 0.92% | 21 |
|
|
2014
Q4 | $18M | Sell |
260,200
-20,600
| -7% | -$1.39M | 1.21% | 17 |
|
|
2014
Q3 | $18.2M | Buy |
280,800
+27,600
| +11% | +$1.75M | 1.22% | 15 |
|
|
2014
Q2 | $15.7M | Buy |
+253,200
| New | +$15.1M | 0.98% | 22 |
|
Other funds holding LLY
Northwest & Ethical Investments's LLY Position: Q2 2026 in Review
Northwest & Ethical Investments reduced its Eli Lilly (LLY) stake by 21% in Q2 2026, selling an estimated $7.31M and leaving 27,350 shares worth $32.8M. The position accounts for 0.76% of the portfolio, ranked #28.
Northwest & Ethical Investments first reported a position in LLY in Q2 2014 and has held it in 49 quarters since. The position peaked at $35.6M in Q4 2025. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Northwest & Ethical Investments held 27,350 shares of Eli Lilly worth $32.8M as of Q2 2026.
- Northwest & Ethical Investments sold 7,151 Eli Lilly shares in Q2 2026, an estimated $7.31M.
- Eli Lilly made up 0.76% of Northwest & Ethical Investments's portfolio in Q2 2026, its #28 holding.
- Northwest & Ethical Investments first reported a position in Eli Lilly in Q2 2014 and has held it in 49 quarters since.
- Northwest & Ethical Investments's Eli Lilly position peaked at $35.6M in Q4 2025.
- 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.